Bimal Bhindi

Urology

5716 Cleveland St Ste 200
Virginia Beach, VA 23462

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 121 publications

Outcomes and Predictors of Recurrence and Survival in Surgically Resected Localized Chromophobe Renal Cell Carcinoma: Results from the Canadian Kidney Cancer Information System (CKCis).

Outcomes and Predictors of Recurrence and Survival in Surgically Resected Localized Chromophobe Renal Cell Carcinoma: Results from the Canadian Kidney Cancer Information System (CKCis).

Journal: Current oncology (Toronto, Ont.)

Published: February 01, 2026

Comparison of partial nephrectomy to radical nephrectomy for non-metastatic cT2 renal tumors: Results from a Canadian Multi-Institutional Collaborative.

Comparison of partial nephrectomy to radical nephrectomy for non-metastatic cT2 renal tumors: Results from a Canadian Multi-Institutional Collaborative.

Journal: Urologic oncology

Published: January 25, 2026

Node Positive Resected Renal Cell Carcinoma Portends a Poor Prognosis: Results From the Canadian Kidney Cancer Collaboration.

Node Positive Resected Renal Cell Carcinoma Portends a Poor Prognosis: Results From the Canadian Kidney Cancer Collaboration.

Journal: Clinical genitourinary cancer

Published: December 19, 2025

Bone Metastases and Use of Bone Protective Agents for Metastatic Clear Cell Renal Cell Carcinoma: A Contemporary National Real-World Analysis.

Bone Metastases and Use of Bone Protective Agents for Metastatic Clear Cell Renal Cell Carcinoma: A Contemporary National Real-World Analysis.

Journal: Clinical genitourinary cancer

Published: December 16, 2025

Reply by Authors.

Reply by Authors.

Journal: The Journal of urology

Published: December 09, 2025

Reply by Authors.

Reply by Authors.

Journal: The Journal of urology

Published: September 24, 2025

Reply by Authors.

Reply by Authors.

Journal: The Journal of urology

Published: September 24, 2025

Incidence of Local Treatment and Metastasis During Active Surveillance for Patients With a Small Renal Mass in a National Multicenter Prospective Cohort.

Incidence of Local Treatment and Metastasis During Active Surveillance for Patients With a Small Renal Mass in a National Multicenter Prospective Cohort.

Journal: The Journal of urology

Published: August 22, 2025

Real-world management and clinical outcomes of first line treatment of advanced renal cell carcinoma in older patients in Canada.

Real-world management and clinical outcomes of first line treatment of advanced renal cell carcinoma in older patients in Canada.

Journal: Journal of geriatric oncology

Published: August 06, 2025

Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary renal cell carcinoma.

Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary renal cell carcinoma.

Journal: The oncologist

Published: May 23, 2025

Urine Glycosaminoglycan Scores for Surveillance of Recurrence in Intermediate- and High-risk Nonmetastatic Clear Cell Renal Cell Carcinoma-An Observational Prospective Multicentre Diagnostic Test Cohort Study.

Urine Glycosaminoglycan Scores for Surveillance of Recurrence in Intermediate- and High-risk Nonmetastatic Clear Cell Renal Cell Carcinoma-An Observational Prospective Multicentre Diagnostic Test Cohort Study.

Journal: European urology oncology

Published: December 23, 2024

Real-World Efficacy and Toxicity of Ipilimumab and Nivolumab as First-Line Treatment of Metastatic Renal Cell Carcinoma (mRCC) in a Subpopulation of Elderly and Poor Performance Status Patients.

Real-World Efficacy and Toxicity of Ipilimumab and Nivolumab as First-Line Treatment of Metastatic Renal Cell Carcinoma (mRCC) in a Subpopulation of Elderly and Poor Performance Status Patients.

Journal: Cancers

Published: December 11, 2024

Showing 1-12 of 121

Last Updated: 09/26/2026